These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2744393

  • 21. Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia.
    Konopleva M, Thall PF, Yi CA, Borthakur G, Coveler A, Bueso-Ramos C, Benito J, Konoplev S, Gu Y, Ravandi F, Jabbour E, Faderl S, Thomas D, Cortes J, Kadia T, Kornblau S, Daver N, Pemmaraju N, Nguyen HQ, Feliu J, Lu H, Wei C, Wilson WR, Melink TJ, Gutheil JC, Andreeff M, Estey EH, Kantarjian H.
    Haematologica; 2015 Jul; 100(7):927-34. PubMed ID: 25682597
    [Abstract] [Full Text] [Related]

  • 22. Study of prognostic significance of marrow angiogenesis assessment in patients with de novo acute leukemia.
    AbdElAal Asmaa A, Afify RA, Zaher AE, ElGammal MM, Atef AM.
    Hematology; 2015 Oct; 20(9):504-10. PubMed ID: 25885121
    [Abstract] [Full Text] [Related]

  • 23. Comparative analysis of methotrexate polyglutamates in lymphoblast preparations from bone marrow and blood, and the contribution of residual red blood cells.
    Weigand M, Frei E, Graf N, Wiessler M.
    J Cancer Res Clin Oncol; 2000 Jul; 126(7):407-11. PubMed ID: 10929763
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Therapy for acute myeloid leukemia and acute lymphoblastic leukemia in adults.
    Geller RB, Larson RA.
    Curr Opin Oncol; 1991 Feb; 3(1):30-8. PubMed ID: 2043696
    [Abstract] [Full Text] [Related]

  • 26. Erythropoietic activities in acute leukemia and in malignant lymphoma with or without bone marrow involvement.
    Choi JW, Pai SH.
    Ann Clin Lab Sci; 2003 Feb; 33(4):407-10. PubMed ID: 14584754
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Polyamines as a prognostic criterion of the duration of clinico-hematologic remission in acute leukemia in children].
    Kovtunova ME, Voronchikhina LD, Riabova TI, Riabov NV.
    Ter Arkh; 1988 Feb; 60(9):77-9. PubMed ID: 3217885
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Abnormalities of the erythropoiesis at the beginning of remission in acute promyelocytic leukemia treated with arabinoside-cytosine].
    Dubois-Ferrière H, Aguercif M, Hazeghi P, Rudhardt M.
    Schweiz Med Wochenschr; 1970 Feb 14; 100(7):321-3. PubMed ID: 5263342
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
    Lee EJ, Schiffer CA, Tomiyasu T, Testa JR.
    Leukemia; 1990 May 14; 4(5):350-3. PubMed ID: 2388480
    [Abstract] [Full Text] [Related]

  • 37. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM, Bunin NJ, Belasco JB, Meek R, Scher C, Lange BJ.
    Med Pediatr Oncol; 2000 May 14; 34(5):313-8. PubMed ID: 10797352
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
    Cortes J, Fayad L, O'Brien S, Keating M, Kantarjian H.
    Clin Cancer Res; 1999 Sep 14; 5(9):2491-7. PubMed ID: 10499624
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.